Global 3D Printed Organ Market - 2024 -2031
Market Overview
The Global 3D printed organ market reached US$ 2.41 billion in 2023 and is expected to reach US$ 6.18 billion by 2031, growing at a CAGR of 12.6% during the forecast period 2024-2031.
A 3D-printed organ is a replica of body tissue created with a 3D bioprinter. They're made out of cellular bio-inks and are artificially grown in a lab. The bioink is designed to help cells build the function and structure of the natural organ it mimics.
Individual patients' distinct anatomical and physiological needs can be addressed using 3D-printed organs. By employing a patient's own cells to construct the organ, the chance of rejection is reduced, resulting in improved outcomes. 3D-printed organs can be used as models to research diseases and test novel medications. This skill enables researchers to gain a better understanding of how diseases affect human tissues and design more effective treatments without having to rely on animal experimentation.
Market Dynamics: Drivers & Restraints
Increasing Prevalence of Chronic Diseases
Chronic disorders such as diabetes, hypertension, and kidney disease are major causes of organ failure. As these disorders become more common around the world, the number of patients seeking organ transplants increases. For instance, there are currently over 103,000 persons on the national transplant waiting list in the United States, with one added every eight minutes, underlining the urgent need for novel approaches like 3D-printed organs to meet this demand.
3D-printed organs can be made from a patient's own cells, increasing biocompatibility and significantly reducing the possibility of transplant rejection. This personalization is especially advantageous for individuals suffering from chronic diseases since it enables individualized treatment options closely aligned with their physiological needs. By addressing compatibility difficulties, 3D-printed organs can boost transplant success rates and patient well-being.
Regulatory Challenges
Regulatory bodies require significant safety and efficacy evidence before approving new medical items. Because 3D-printed organs are custom-made for each patient, typical testing methods such as randomized controlled trials may be ineffective. Each organ is unique, making it difficult to predict outcomes from one example to the next, raising questions about the dependability of safety statistics. The inability to test organs on other people before implantation hampers regulatory evaluations.
Meeting regulatory criteria can be excessively expensive, particularly for bioprinting startups and smaller organizations. Extensive study, testing, and paperwork are required to establish compliance with safety regulations, which may discourage investment and limit innovation. The cost difficulty of navigating regulatory processes may limit the number of market participants.
Market Segment Analysis
The global 3D printed organ market is segmented based on type, material, fixation type, technology, end-user and region.
Type:
Kidney segment is expected to dominate the 3D-printed organ market share
The kidney segment is likely to dominate the 3D printed organ market due to several compelling factors, including increasing demand for innovative organ transplantation options, rising number of individuals with chronic kidney diseases and others. Kidney transplants account for a substantial share of organ transplant treatments worldwide. For instance, according to the United Network for Organ Sharing, in 2022, 42,887 organ transplants were performed in the United States, an increase of 3.7 percent over 2021.
The significant shortage of suitable donor kidneys is a pressing issue, with over 110,000 people on waiting lists for organ transplants in the United States. Many patients have lengthy waits for a qualified donor, which might last many years. This scarcity emphasizes the urgent requirement for alternative alternatives, such as 3D-printed kidneys, which could be an appealing choice for patients who would otherwise face long wait times or rely on dialysis treatments.
Recent advancements in bioprinting technologies are focused on tackling the complex structures of kidneys, which improves the chances of successfully creating these engineered organs for transplantation. Researchers are consistently improving methods to accurately replicate the intricate functions of kidneys, which is essential for developing organs that can perform the necessary biological tasks effectively.
Market Geographical Share
North America is expected to hold a significant position in the 3D-printed organ market share
North America is at the forefront of the 3D printed organ market, driven by a combination of a strong healthcare system, significant investments in research and development, and an increasing demand for organ transplants. The region has a well-established healthcare infrastructure that supports advanced medical research and innovation, facilitating the integration of cutting-edge technologies like 3D printing into clinical practice. This environment enables rapid advancements in the fabrication of organs.
Moreover, substantial investments from both government and private sectors are directed towards advancing bioprinting technologies in North America. These investments are crucial for developing innovative solutions to address the complexities involved in organ printing, including enhancing bioink formulations and refining printing techniques.
Rising government initiatives to meet the rising demand for organs are also contributing to the overall region’s market growth. For instance, In March 2024, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS), announced the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program. The PRINT program aims to create a process to enable biofabrication of the kidney, heart, and liver by leveraging 3D bioprinting, cell manufacturing, biomaterials, modeling, and tissue engineering. The goal is to use patient cells or a biobank to quickly produce immune matched replacement organs and restore normal organ function. These factors are expected to contribute to the region’s market growth.
Asia-Pacific is growing at the fastest pace in the 3D-printed organ market
Asia-Pacific is expected to experience the fastest growth in the global 3D-printed organ market. This is due to rising technological advancement, increasing research and capabilities, and rising funding from the government.
The region faces a significant demand for organ transplants. For instance, according to the publication by Taipei Times in 2022, organ donor registrations dropped by 48 percent during the COVID-19 pandemic, Taiwan Organ Sharing Registry and Patient Autonomy Promotion Center data show. As of the end of June, more than 10,000 people were waiting to receive an organ transplant, including 8,254 people waiting for a kidney, 1,002 people waiting for a liver, 217 people waiting for a heart, 93 people waiting for a lung, and 89 people waiting for a pancreas. Thus, the above factors are rising the region’s growth.
Market Competitive Landscape
The major global players in the 3D-printed organ market include CELLINK, Organovo Holdings Inc., CYFUSE BIOMEDICAL K.K., 3D Systems, Inc., Stratasys, United Therapeutics Corporation, Prellis Biologics, CollPlant Biotechnologies Ltd., Aspect Biosystems Ltd. and Materialise among others.
Why Purchase the Report?
Target Audience 2024
The Global 3D printed organ market reached US$ 2.41 billion in 2023 and is expected to reach US$ 6.18 billion by 2031, growing at a CAGR of 12.6% during the forecast period 2024-2031.
A 3D-printed organ is a replica of body tissue created with a 3D bioprinter. They're made out of cellular bio-inks and are artificially grown in a lab. The bioink is designed to help cells build the function and structure of the natural organ it mimics.
Individual patients' distinct anatomical and physiological needs can be addressed using 3D-printed organs. By employing a patient's own cells to construct the organ, the chance of rejection is reduced, resulting in improved outcomes. 3D-printed organs can be used as models to research diseases and test novel medications. This skill enables researchers to gain a better understanding of how diseases affect human tissues and design more effective treatments without having to rely on animal experimentation.
Market Dynamics: Drivers & Restraints
Increasing Prevalence of Chronic Diseases
Chronic disorders such as diabetes, hypertension, and kidney disease are major causes of organ failure. As these disorders become more common around the world, the number of patients seeking organ transplants increases. For instance, there are currently over 103,000 persons on the national transplant waiting list in the United States, with one added every eight minutes, underlining the urgent need for novel approaches like 3D-printed organs to meet this demand.
3D-printed organs can be made from a patient's own cells, increasing biocompatibility and significantly reducing the possibility of transplant rejection. This personalization is especially advantageous for individuals suffering from chronic diseases since it enables individualized treatment options closely aligned with their physiological needs. By addressing compatibility difficulties, 3D-printed organs can boost transplant success rates and patient well-being.
Regulatory Challenges
Regulatory bodies require significant safety and efficacy evidence before approving new medical items. Because 3D-printed organs are custom-made for each patient, typical testing methods such as randomized controlled trials may be ineffective. Each organ is unique, making it difficult to predict outcomes from one example to the next, raising questions about the dependability of safety statistics. The inability to test organs on other people before implantation hampers regulatory evaluations.
Meeting regulatory criteria can be excessively expensive, particularly for bioprinting startups and smaller organizations. Extensive study, testing, and paperwork are required to establish compliance with safety regulations, which may discourage investment and limit innovation. The cost difficulty of navigating regulatory processes may limit the number of market participants.
Market Segment Analysis
The global 3D printed organ market is segmented based on type, material, fixation type, technology, end-user and region.
Type:
Kidney segment is expected to dominate the 3D-printed organ market share
The kidney segment is likely to dominate the 3D printed organ market due to several compelling factors, including increasing demand for innovative organ transplantation options, rising number of individuals with chronic kidney diseases and others. Kidney transplants account for a substantial share of organ transplant treatments worldwide. For instance, according to the United Network for Organ Sharing, in 2022, 42,887 organ transplants were performed in the United States, an increase of 3.7 percent over 2021.
The significant shortage of suitable donor kidneys is a pressing issue, with over 110,000 people on waiting lists for organ transplants in the United States. Many patients have lengthy waits for a qualified donor, which might last many years. This scarcity emphasizes the urgent requirement for alternative alternatives, such as 3D-printed kidneys, which could be an appealing choice for patients who would otherwise face long wait times or rely on dialysis treatments.
Recent advancements in bioprinting technologies are focused on tackling the complex structures of kidneys, which improves the chances of successfully creating these engineered organs for transplantation. Researchers are consistently improving methods to accurately replicate the intricate functions of kidneys, which is essential for developing organs that can perform the necessary biological tasks effectively.
Market Geographical Share
North America is expected to hold a significant position in the 3D-printed organ market share
North America is at the forefront of the 3D printed organ market, driven by a combination of a strong healthcare system, significant investments in research and development, and an increasing demand for organ transplants. The region has a well-established healthcare infrastructure that supports advanced medical research and innovation, facilitating the integration of cutting-edge technologies like 3D printing into clinical practice. This environment enables rapid advancements in the fabrication of organs.
Moreover, substantial investments from both government and private sectors are directed towards advancing bioprinting technologies in North America. These investments are crucial for developing innovative solutions to address the complexities involved in organ printing, including enhancing bioink formulations and refining printing techniques.
Rising government initiatives to meet the rising demand for organs are also contributing to the overall region’s market growth. For instance, In March 2024, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS), announced the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program. The PRINT program aims to create a process to enable biofabrication of the kidney, heart, and liver by leveraging 3D bioprinting, cell manufacturing, biomaterials, modeling, and tissue engineering. The goal is to use patient cells or a biobank to quickly produce immune matched replacement organs and restore normal organ function. These factors are expected to contribute to the region’s market growth.
Asia-Pacific is growing at the fastest pace in the 3D-printed organ market
Asia-Pacific is expected to experience the fastest growth in the global 3D-printed organ market. This is due to rising technological advancement, increasing research and capabilities, and rising funding from the government.
The region faces a significant demand for organ transplants. For instance, according to the publication by Taipei Times in 2022, organ donor registrations dropped by 48 percent during the COVID-19 pandemic, Taiwan Organ Sharing Registry and Patient Autonomy Promotion Center data show. As of the end of June, more than 10,000 people were waiting to receive an organ transplant, including 8,254 people waiting for a kidney, 1,002 people waiting for a liver, 217 people waiting for a heart, 93 people waiting for a lung, and 89 people waiting for a pancreas. Thus, the above factors are rising the region’s growth.
Market Competitive Landscape
The major global players in the 3D-printed organ market include CELLINK, Organovo Holdings Inc., CYFUSE BIOMEDICAL K.K., 3D Systems, Inc., Stratasys, United Therapeutics Corporation, Prellis Biologics, CollPlant Biotechnologies Ltd., Aspect Biosystems Ltd. and Materialise among others.
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
Target Audience 2024
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Organ Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Chronic Diseases
4.1.2. Restraints
4.1.2.1. Regulatory Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. BY ORGAN TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
6.1.2. Market Attractiveness Index, By Organ Type
6.2. Heart*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Liver
6.4. Kidney
6.5. Lung
6.6. Skin
6.7. Bone
7. BY TECHNOLOGY
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Extrusion-Based 3D Printing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Laser-Assisted Printing
7.4. Inkjet Printing
7.5. Magnetic Levitation
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Tissue Engineering*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Regenerative Medicine
8.4. Drug Discovery
8.5. Surgical Planning
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals and Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research Institutes and Laboratories
9.4. Pharmaceutical Companies
9.5. Academic Institutions
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. The U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. CELLINK*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. SynCOrganovo Holdings Inc.
12.3. CYFUSE BIOMEDICAL K.K.
12.4. 3D Systems, Inc.
12.5. Stratasys
12.6. United Therapeutics Corporation
12.7. Prellis Biologics
12.8. CollPlant Biotechnologies Ltd.
12.9. Aspect Biosystems Ltd.
12.10. Materialise (*LIST NOT EXHAUSTIVE)
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Organ Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Chronic Diseases
4.1.2. Restraints
4.1.2.1. Regulatory Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. BY ORGAN TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
6.1.2. Market Attractiveness Index, By Organ Type
6.2. Heart*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Liver
6.4. Kidney
6.5. Lung
6.6. Skin
6.7. Bone
7. BY TECHNOLOGY
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Extrusion-Based 3D Printing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Laser-Assisted Printing
7.4. Inkjet Printing
7.5. Magnetic Levitation
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Tissue Engineering*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Regenerative Medicine
8.4. Drug Discovery
8.5. Surgical Planning
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals and Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research Institutes and Laboratories
9.4. Pharmaceutical Companies
9.5. Academic Institutions
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. The U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Organ Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. CELLINK*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. SynCOrganovo Holdings Inc.
12.3. CYFUSE BIOMEDICAL K.K.
12.4. 3D Systems, Inc.
12.5. Stratasys
12.6. United Therapeutics Corporation
12.7. Prellis Biologics
12.8. CollPlant Biotechnologies Ltd.
12.9. Aspect Biosystems Ltd.
12.10. Materialise (*LIST NOT EXHAUSTIVE)
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
LIST OF TABLES
Table 1 Global 3D-Printed Organ Market Value, By Organ Type, 2023, 2027 & 2031 (US$ Million)
Table 2 Global 3D-Printed Organ Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)
Table 3 Global 3D-Printed Organ Market Value, By Application, 2023, 2027 & 2031 (US$ Million)
Table 4 Global 3D-Printed Organ Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 5 Global 3D-Printed Organ Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 6 Global 3D-Printed Organ Market Value, By Organ Type, 2023, 2027 & 2031 (US$ Million)
Table 7 Global 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 8 Global 3D-Printed Organ Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)
Table 9 Global 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 10 Global 3D-Printed Organ Market Value, By Application, 2023, 2027 & 2031 (US$ Million)
Table 11 Global 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 12 Global 3D-Printed Organ Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 13 Global 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 14 Global 3D-Printed Organ Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 15 Global 3D-Printed Organ Market Value, By Region, 2022-2031 (US$ Million)
Table 16 North America 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 17 North America 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 18 North America 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 19 North America 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 20 North America 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 21 Asia-Pacific 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 22 Asia-Pacific 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 23 Asia-Pacific 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 24 Asia-Pacific 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 25 Asia-Pacific 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 26 Europe 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 27 Europe 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 28 Europe 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 29 Europe 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 30 Europe 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 31 South America 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 32 South America 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 33 South America 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 34 South America 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 35 South America 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 36 Middle East and Africa 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 37 Middle East and Africa 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 38 Middle East and Africa 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 39 Middle East and Africa 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 40 Middle East and Africa 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 41 CELLINK: Overview
Table 42 CELLINK: Product Portfolio
Table 43 CELLINK: Key Developments
Table 44 Organovo Holdings Inc.: Overview
Table 45 Organovo Holdings Inc.: Product Portfolio
Table 46 Organovo Holdings Inc.: Key Developments
Table 47 CYFUSE BIOMEDICAL K.K.: Overview
Table 48 CYFUSE BIOMEDICAL K.K.: Product Portfolio
Table 49 CYFUSE BIOMEDICAL K.K.: Key Developments
Table 50 3D Systems, Inc.: Overview
Table 51 3D Systems, Inc.: Product Portfolio
Table 52 3D Systems, Inc.: Key Developments
Table 53 Stratasys: Overview
Table 54 Stratasys: Product Portfolio
Table 55 Stratasys: Key Developments
Table 56 United Therapeutics Corporation: Overview
Table 57 United Therapeutics Corporation: Product Portfolio
Table 58 United Therapeutics Corporation: Key Developments
Table 59 Prellis Biologics: Overview
Table 60 Prellis Biologics: Product Portfolio
Table 61 Prellis Biologics: Key Developments
Table 62 CollPlant Biotechnologies Ltd.: Overview
Table 63 CollPlant Biotechnologies Ltd.: Product Portfolio
Table 64 CollPlant Biotechnologies Ltd.: Key Developments
Table 65 Aspect Biosystems Ltd.: Overview
Table 66 Aspect Biosystems Ltd.: Product Portfolio
Table 67 Aspect Biosystems Ltd.: Key Developments
Table 68 Materialise: Overview
Table 69 Materialise: Product Portfolio
Table 70 Materialise: Key Developments
Table 1 Global 3D-Printed Organ Market Value, By Organ Type, 2023, 2027 & 2031 (US$ Million)
Table 2 Global 3D-Printed Organ Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)
Table 3 Global 3D-Printed Organ Market Value, By Application, 2023, 2027 & 2031 (US$ Million)
Table 4 Global 3D-Printed Organ Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 5 Global 3D-Printed Organ Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 6 Global 3D-Printed Organ Market Value, By Organ Type, 2023, 2027 & 2031 (US$ Million)
Table 7 Global 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 8 Global 3D-Printed Organ Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)
Table 9 Global 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 10 Global 3D-Printed Organ Market Value, By Application, 2023, 2027 & 2031 (US$ Million)
Table 11 Global 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 12 Global 3D-Printed Organ Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 13 Global 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 14 Global 3D-Printed Organ Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 15 Global 3D-Printed Organ Market Value, By Region, 2022-2031 (US$ Million)
Table 16 North America 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 17 North America 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 18 North America 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 19 North America 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 20 North America 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 21 Asia-Pacific 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 22 Asia-Pacific 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 23 Asia-Pacific 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 24 Asia-Pacific 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 25 Asia-Pacific 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 26 Europe 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 27 Europe 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 28 Europe 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 29 Europe 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 30 Europe 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 31 South America 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 32 South America 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 33 South America 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 34 South America 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 35 South America 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 36 Middle East and Africa 3D-Printed Organ Market Value, By Organ Type, 2022-2031 (US$ Million)
Table 37 Middle East and Africa 3D-Printed Organ Market Value, By Technology, 2022-2031 (US$ Million)
Table 38 Middle East and Africa 3D-Printed Organ Market Value, By Application, 2022-2031 (US$ Million)
Table 39 Middle East and Africa 3D-Printed Organ Market Value, By End-User, 2022-2031 (US$ Million)
Table 40 Middle East and Africa 3D-Printed Organ Market Value, By Country, 2022-2031 (US$ Million)
Table 41 CELLINK: Overview
Table 42 CELLINK: Product Portfolio
Table 43 CELLINK: Key Developments
Table 44 Organovo Holdings Inc.: Overview
Table 45 Organovo Holdings Inc.: Product Portfolio
Table 46 Organovo Holdings Inc.: Key Developments
Table 47 CYFUSE BIOMEDICAL K.K.: Overview
Table 48 CYFUSE BIOMEDICAL K.K.: Product Portfolio
Table 49 CYFUSE BIOMEDICAL K.K.: Key Developments
Table 50 3D Systems, Inc.: Overview
Table 51 3D Systems, Inc.: Product Portfolio
Table 52 3D Systems, Inc.: Key Developments
Table 53 Stratasys: Overview
Table 54 Stratasys: Product Portfolio
Table 55 Stratasys: Key Developments
Table 56 United Therapeutics Corporation: Overview
Table 57 United Therapeutics Corporation: Product Portfolio
Table 58 United Therapeutics Corporation: Key Developments
Table 59 Prellis Biologics: Overview
Table 60 Prellis Biologics: Product Portfolio
Table 61 Prellis Biologics: Key Developments
Table 62 CollPlant Biotechnologies Ltd.: Overview
Table 63 CollPlant Biotechnologies Ltd.: Product Portfolio
Table 64 CollPlant Biotechnologies Ltd.: Key Developments
Table 65 Aspect Biosystems Ltd.: Overview
Table 66 Aspect Biosystems Ltd.: Product Portfolio
Table 67 Aspect Biosystems Ltd.: Key Developments
Table 68 Materialise: Overview
Table 69 Materialise: Product Portfolio
Table 70 Materialise: Key Developments
LIST OF FIGURES
Figure 1 Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 2 Global 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 3 Global 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 4 Global 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 5 Global 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 6 Global 3D-Printed Organ Market Share, By Region, 2023 & 2031 (%)
Figure 7 Global 3D-Printed Organ Market Y-o-Y Growth, By Organ Type, 2023-2031 (%)
Figure 8 Heart 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 9 Liver 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 10 Kidney 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 11 Lung 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 12 Skin 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 13 Bone 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 14 Global 3D-Printed Organ Market Y-o-Y Growth, By Technology, 2023-2031 (%)
Figure 15 Extrusion-Based 3D Printing Technology in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 16 Laser-Assisted Printing Technology in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 17 Inkjet Printing Technology in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 18 Magnetic Levitation Technology in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 19 Global 3D-Printed Organ Market Y-o-Y Growth, By Application, 2023-2031 (%)
Figure 20 Tissue Engineering Application in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 21 Regenerative Medicine Application in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 22 Drug Discovery Application in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 23 Surgical Planning Application in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 24 Global 3D-Printed Organ Market Y-o-Y Growth, By End-User, 2023-2031 (%)
Figure 25 Hospitals and Clinics End-User in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 26 Research Institutes and Laboratories End-User in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 27 Pharmaceutical Companies End-User in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 28 Academic Institutions End-User in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 29 Global 3D-Printed Organ Market Y-o-Y Growth, By Region, 2023-2031 (%)
Figure 30 North America 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 31 North America 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 32 North America 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 33 North America 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 34 North America 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 35 North America 3D-Printed Organ Market Share, By Country, 2023 & 2031 (%)
Figure 36 Asia-Pacific 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 37 Asia-Pacific 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 38 Asia-Pacific 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 39 Asia-Pacific 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 40 Asia-Pacific 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 41 Asia-Pacific 3D-Printed Organ Market Share, By Country, 2023 & 2031 (%)
Figure 42 Europe 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 43 Europe 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 44 Europe 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 45 Europe 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 46 Europe 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 47 Europe 3D-Printed Organ Market Share, By Country, 2023 & 2031 (%)
Figure 48 South America 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 49 South America 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 50 South America 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 51 South America 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 52 South America 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 53 South America 3D-Printed Organ Market Share, By Country, 2023 & 2031 (%)
Figure 54 Middle East and Africa 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 55 Middle East and Africa 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 56 Middle East and Africa 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 57 Middle East and Africa 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 58 Middle East and Africa 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 59 CELLINK: Financials
Figure 60 Organovo Holdings Inc.: Financials
Figure 61 CYFUSE BIOMEDICAL K.K.: Financials
Figure 62 3D Systems, Inc.: Financials
Figure 63 Stratasys: Financials
Figure 64 United Therapeutics Corporation: Financials
Figure 65 Prellis Biologics: Financials
Figure 66 CollPlant Biotechnologies Ltd.: Financials
Figure 67 Aspect Biosystems Ltd.: Financials
Figure 68 Materialise: Financials
Figure 1 Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 2 Global 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 3 Global 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 4 Global 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 5 Global 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 6 Global 3D-Printed Organ Market Share, By Region, 2023 & 2031 (%)
Figure 7 Global 3D-Printed Organ Market Y-o-Y Growth, By Organ Type, 2023-2031 (%)
Figure 8 Heart 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 9 Liver 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 10 Kidney 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 11 Lung 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 12 Skin 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 13 Bone 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 14 Global 3D-Printed Organ Market Y-o-Y Growth, By Technology, 2023-2031 (%)
Figure 15 Extrusion-Based 3D Printing Technology in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 16 Laser-Assisted Printing Technology in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 17 Inkjet Printing Technology in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 18 Magnetic Levitation Technology in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 19 Global 3D-Printed Organ Market Y-o-Y Growth, By Application, 2023-2031 (%)
Figure 20 Tissue Engineering Application in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 21 Regenerative Medicine Application in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 22 Drug Discovery Application in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 23 Surgical Planning Application in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 24 Global 3D-Printed Organ Market Y-o-Y Growth, By End-User, 2023-2031 (%)
Figure 25 Hospitals and Clinics End-User in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 26 Research Institutes and Laboratories End-User in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 27 Pharmaceutical Companies End-User in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 28 Academic Institutions End-User in Global 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 29 Global 3D-Printed Organ Market Y-o-Y Growth, By Region, 2023-2031 (%)
Figure 30 North America 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 31 North America 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 32 North America 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 33 North America 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 34 North America 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 35 North America 3D-Printed Organ Market Share, By Country, 2023 & 2031 (%)
Figure 36 Asia-Pacific 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 37 Asia-Pacific 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 38 Asia-Pacific 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 39 Asia-Pacific 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 40 Asia-Pacific 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 41 Asia-Pacific 3D-Printed Organ Market Share, By Country, 2023 & 2031 (%)
Figure 42 Europe 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 43 Europe 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 44 Europe 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 45 Europe 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 46 Europe 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 47 Europe 3D-Printed Organ Market Share, By Country, 2023 & 2031 (%)
Figure 48 South America 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 49 South America 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 50 South America 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 51 South America 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 52 South America 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 53 South America 3D-Printed Organ Market Share, By Country, 2023 & 2031 (%)
Figure 54 Middle East and Africa 3D-Printed Organ Market Value, 2022-2031 (US$ Million)
Figure 55 Middle East and Africa 3D-Printed Organ Market Share, By Organ Type, 2023 & 2031 (%)
Figure 56 Middle East and Africa 3D-Printed Organ Market Share, By Technology, 2023 & 2031 (%)
Figure 57 Middle East and Africa 3D-Printed Organ Market Share, By Application, 2023 & 2031 (%)
Figure 58 Middle East and Africa 3D-Printed Organ Market Share, By End-User, 2023 & 2031 (%)
Figure 59 CELLINK: Financials
Figure 60 Organovo Holdings Inc.: Financials
Figure 61 CYFUSE BIOMEDICAL K.K.: Financials
Figure 62 3D Systems, Inc.: Financials
Figure 63 Stratasys: Financials
Figure 64 United Therapeutics Corporation: Financials
Figure 65 Prellis Biologics: Financials
Figure 66 CollPlant Biotechnologies Ltd.: Financials
Figure 67 Aspect Biosystems Ltd.: Financials
Figure 68 Materialise: Financials
